XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Officer
Common Stock
Additional Paid-in Capital
Officer
Additional Paid-in Capital
Accumulated Deficit
Officer
Total
Balance at the beginning at Jun. 30, 2023       $ 12,462 $ (4,883)   $ 7,579
Balance at the beginning (in shares) at Jun. 30, 2023   10,685,778          
Grant of options to officer       5     5
Net profit (loss)         439   439
Balance at the end at Sep. 30, 2023       12,467 (4,444)   8,023
Balance at the end (in shares) at Sep. 30, 2023   10,685,778          
Grant of options to officer       5     5
Share buyback and cancellation       (101)     (101)
Share buyback and cancellation (in shares)   (109,135)          
Net profit (loss)         (794)   (794)
Balance at the end at Dec. 31, 2023       12,371 (5,238)   7,133
Balance at the end (in shares) at Dec. 31, 2023   10,576,643          
Grant of options to officer       5     5
Issuance of stock to directors       13     13
Issuance of stock to directors (in shares)   18,938          
Share buyback and cancellation     $ (33) (200)   $ (33) (200)
Share buyback and cancellation (in shares) (49,586) (260,024)          
Net profit (loss)         (601)   (601)
Balance at the end at Mar. 31, 2024       12,157 (5,840)   6,317
Balance at the end (in shares) at Mar. 31, 2024   10,285,971          
Balance at the beginning at Jun. 30, 2024       11,965 (6,255)   5,710
Balance at the beginning (in shares) at Jun. 30, 2024   9,896,850          
Grant of options to officer       5     5
Net profit (loss)         (25)   (25)
Balance at the end at Sep. 30, 2024       11,970 (6,281)   5,690
Balance at the end (in shares) at Sep. 30, 2024   9,896,850          
Grant of options to officer       32     32
Net profit (loss)         (527)   (527)
Balance at the end at Dec. 31, 2024       12,003 (6,808)   5,195
Balance at the end (in shares) at Dec. 31, 2024   9,896,850          
Grant of options to officer       11     11
Issuance of stock to directors       23     23
Issuance of stock to directors (in shares)   36,829          
Repriced options for directors and officer       11     11
Net profit (loss)         (240)   (240)
Balance at the end at Mar. 31, 2025       $ 12,047 $ (7,048)   $ 4,999
Balance at the end (in shares) at Mar. 31, 2025   9,933,679